Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

PFE:SS

298.000 SEK 6.000 2.05%

As of 12:30:00 ET on 03/27/2015.

Snapshot for Pfizer Inc (PFE)

Open: 287.500 Day's Range: 287.500 - 298.000 Volume: 2,416
Previous Close: 292.000 52wk Range: 185.500 - 300.000 1-Yr Rtn: +48.35%

Stock Chart for PFE

No chart data available.
  • PFE:SS 295.000
  • 1D
  • 1M
  • 1Y
292.000
Interactive PFE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PFE

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 16.7232
Relative P/E vs. OMX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2015) 2.0790
Est. PEG Ratio 3.3050
Market Cap (M SEK) 1,829,819.41
Shares Outstanding (M) 6,140.33
30 Day Average Volume 4,667
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 3.13%
Cash Dividend (USD) 0.2800
Dividend Ex-Date 02/05/2015
5 Year Dividend Growth 9.77%
Next Earnings Announcement 04/28/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PFE

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PFE

Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.

Ian C ReadChairman/CEOGeno J GermanoPres:Global Innovative Pharma
Albert BourlaPres:Vaccines & OncologyMikael DolstenPres:Worldwide Research & Dev
More Company Profile & Key Executives for PFE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil